Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.02 0.01  (0.5%)
TradingVolume：1510.25
04-30
2025
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN ...
Publisher：
04-29
2025
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2025
Publisher：
04-29
2025
NOTICE OF ANNUAL GENERAL MEETING
Publisher：
04-29
2025
Environmental, Social and Governance Report 2024
Publisher：
04-29
2025
Annual Report 2024
Publisher：
04-10
2025
VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM
Publisher：
04-07
2025
VOLUNTARY ANNOUNCEMENT CLASS 1 INNOVATIVE ANTIDEPRESSANT RUOXINLIN APPROVED FOR MARKETING IN MACAO
Publisher：
04-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Publisher：
03-31
2025
VOLUNTARY ANNOUNCEMENT RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN JAPAN
Publisher：
03-30
2025
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：1510.25
2.02
0.01  (0.5%)
Announcement & Circular
04-30
2025
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN NINE YEARS ON THE BOARD AND NOTICE OF ANNUAL GENERAL MEETING
04-29
2025
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2025
04-29
2025
NOTICE OF ANNUAL GENERAL MEETING
04-29
2025
Environmental, Social and Governance Report 2024
04-29
2025
Annual Report 2024
04-10
2025
VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM
04-07
2025
VOLUNTARY ANNOUNCEMENT CLASS 1 INNOVATIVE ANTIDEPRESSANT RUOXINLIN APPROVED FOR MARKETING IN MACAO
04-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
03-31
2025
VOLUNTARY ANNOUNCEMENT RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN JAPAN
03-30
2025
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
First
1
2
3
4
5
Last